1 Department of Radiology, Gifu University, 1-1 Yanagido, Gifu 501-1194, Japan.
2 Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, PA.
AJR Am J Roentgenol. 2018 Jun;210(6):1252-1258. doi: 10.2214/AJR.17.18595. Epub 2018 Apr 9.
The objective of our study was to assess the preoperative resectability of pancreatic ductal adenocarcinoma (PDAC) using the National Comprehensive Cancer Network (NCCN) guideline, the general rules of the Japan Pancreas Society (JPS), and both of them combined.
Eighty-six consecutive patients with PDAC (50 men and 36 women; mean age ± SD, 70.8 ± 9.0 years; age range, 49-86 years) underwent dynamic contrast-enhanced CT. Following the NCCN guideline, the degree of vascular invasion was evaluated to determine the NCCN score: 0 points for absence of vascular invasion, 1 point for tumor contact ≤ 180°, and 2 points for tumor contact > 180°. Direct invasion to adjacent structures was rated according to the general rules of JPS to determine the JPS score: 0 points for absence and 1 point for presence. The NCCN score, JPS score, and sum of the two scores, which we refer to as the "combined score," were compared with histopathologic or intraoperative findings as well as for the differentiation of R0 resection (negative resection margins) from R1 (microscopic tumor infiltration) and R2 (macroscopic residual tumor) using ROC curve analysis.
The sensitivities, specificities, and areas under the ROC curves (AUCs) for the differentiation of R0 from R1 and R2 were 100.0%, 40.0%, and 0.725, respectively, with the NCCN score; 63.9%, 84.0%, and 0.824 with the JPS score; and 86.9%, 68.0%, and 0.874 with the combined score. The AUC of the combined score was significantly greater than that of the NCCN score (p = 0.0059).
The assessment of resectability of PDAC based on the combined criteria of the NCCN guideline and general rules of JPS was superior to that based on either criterion alone.
本研究旨在评估使用美国国家综合癌症网络(NCCN)指南、日本胰腺学会(JPS)一般规则以及两者结合对胰腺导管腺癌(PDAC)术前可切除性的评估。
86 例连续 PDAC 患者(男 50 例,女 36 例;平均年龄±标准差,70.8±9.0 岁;年龄范围,49-86 岁)接受了动态对比增强 CT 检查。根据 NCCN 指南,评估血管侵犯程度以确定 NCCN 评分:无血管侵犯得 0 分,肿瘤接触≤180°得 1 分,肿瘤接触>180°得 2 分。根据 JPS 一般规则评估直接侵犯相邻结构以确定 JPS 评分:无侵犯得 0 分,有侵犯得 1 分。NCCN 评分、JPS 评分和两者之和(我们称为“综合评分”)与组织病理学或术中发现进行比较,并使用 ROC 曲线分析对 R0 切除(阴性切缘)与 R1(显微镜下肿瘤浸润)和 R2(肉眼残留肿瘤)进行区分。
NCCN 评分对 R0 与 R1 和 R2 区分的灵敏度、特异性和 ROC 曲线下面积(AUC)分别为 100.0%、40.0%和 0.725;JPS 评分分别为 63.9%、84.0%和 0.824;综合评分分别为 86.9%、68.0%和 0.874。综合评分的 AUC 明显大于 NCCN 评分(p=0.0059)。
基于 NCCN 指南和 JPS 一般规则的综合标准评估 PDAC 的可切除性优于基于单一标准的评估。